Processing

Please wait...

Settings

Settings

Goto Application

1. WO2011126948 - PANCREATIC BETA-CELL MELATONIN RECEPTOR ACTIVATION AS A TREATMENT FOR PRESERVATION OF BETA-CELL MASS AND FUNCTION IN TYPE 2 DIABETES

Publication Number WO/2011/126948
Publication Date 13.10.2011
International Application No. PCT/US2011/030979
International Filing Date 01.04.2011
IPC
A01N 43/38 2006.1
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
43Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
34having rings with one nitrogen atom as the only ring hetero atom
36five-membered rings
38condensed with carbocyclic rings
CPC
A61K 31/4045
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
403condensed with carbocyclic rings, e.g. carbazole
404Indoles, e.g. pindolol
4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
Applicants
  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US]/[US] (AllExceptUS)
  • BUTLER, Peter, C. [US]/[US] (UsOnly)
  • MATVEYENKO, Alekesey, V. [US]/[US] (UsOnly)
Inventors
  • BUTLER, Peter, C.
  • MATVEYENKO, Alekesey, V.
Agents
  • SHERWOOD, Pamela, J.
Priority Data
61/341,91106.04.2010US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) PANCREATIC BETA-CELL MELATONIN RECEPTOR ACTIVATION AS A TREATMENT FOR PRESERVATION OF BETA-CELL MASS AND FUNCTION IN TYPE 2 DIABETES
(FR) ACTIVATION DU RÉCEPTEUR DE LA MÉLATONINE DES CELLULES BÊTA DES ÎLOTS DE LANGERHANS DU PANCRÉAS À DES FINS THÉRAPEUTIQUES EN VUE DE LA PRÉSERVATION DE LA MASSE ET DE L'ACTIVITÉ DES ÎLOTS DE LANGERHANS DANS LE DIABÈTE DE TYPE 2
Abstract
(EN) Methods and compositions are provided for the treatment of diseases related to hyperglycemic conditions, including type 2 diabetes mellitus.
(FR) La présente invention concerne des méthodes et des compositions utilisées pour le traitement de maladies associées à des affections hyperglycémiques, dont le diabète sucré de type 2.
Latest bibliographic data on file with the International Bureau